Literature DB >> 32199494

Estimation of COVID-19 outbreak size in Italy.

Ashleigh R Tuite1, Victoria Ng2, Erin Rees3, David Fisman4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32199494      PMCID: PMC7271205          DOI: 10.1016/S1473-3099(20)30227-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
Italy is currently experiencing an epidemic of COVID-19 which emerged in the Lombardy region. During the interval between Feb 25–29, 2020, we identified 46 cases of COVID-19 reported in 21 countries in Europe, Africa, North America, and South America that were either in individuals with recent travel from Italy, or who had presumed infection by a traveller from Italy. In six cases, in four of the affected countries (Switzerland, France, Austria, and Croatia), land travel was a likely route of introduction, or was documented to have been the route of introduction. We used air travel volume between Italian cities and cities in other countries as an index of connectedness, using data available from the International Air Transport Association for February, 2015, (2·61 million total departing international air passengers from Italy). We used the methods of Fraser and collegues to estimate the size of the underlying epidemic in Italy necessary for these cases to be observed with a reasonable probability. To estimate the time at risk of COVID-19 exposure for travellers departing Italy, we obtained data from the United Nations World Tourism Organization for the proportion of international travelers that are non-residents of Italy (63%) and the average length of stay of tourists to Italy (3·4 days), and assumed the Italian epidemic began 1 month preceding Feb 29, 2020. We also did sensitivity analyses in which we included outbound travel to all countries regardless of reported case importations, inflated travel volumes by 35%, to account for the relative increase in flight numbers from 2015–19, and excluded cases in bordering countries or which were documented to have been introduced by overland travel. When all cases were considered we estimated a true outbreak size of 3971 cases (95% CI 2907–5297), as compared with a reported case count of 1128 on Feb 29, 2020, suggesting non-identification of 72% (61–79%) of cases. In sensitivity analyses, outbreak sizes varied from 1552 to 4533 cases (implying non-identification of 27–75% of cases; table ).
Table

Estimated COVID-19 outbreak size, Italy, Feb 29, 2020

Estimate95% CI% Unreported*Unreported range (%)*
All cases39712907–52977261–79
All cases (adjusted to 2019)29372150–39176248–71
Exclude bordering countries and overland travel45333238–61727565–82
Exclude bordering countries and overland travel (adjusted to 2019)33522395–45646653–75
Include travel to all countries20991500–28594625–60
Include travel to all countries (adjusted to 2019)15521109–2114270–47

Based on reported case count of 1128.

Estimated COVID-19 outbreak size, Italy, Feb 29, 2020 Based on reported case count of 1128. We have previously used similar methods to estimate a much larger epidemic size in Iran, with a far greater degree of under-reporting, based on many fewer exported cases. The reason for this difference relates to the relatively high volume of travel from Italy, relative to Iran. In summary, we suggest that the numerous COVID-19 case exportations from Italy in recent days indicate an epidemic that is larger than official case counts suggest, and which is approximately on a par with that currently occurring in South Korea, which reported 3526 cases (and fewer deaths) as of Feb 29, 2020. Since initial submission of this letter, aggressive case finding efforts combined with ongoing epidemic growth have resulted in a dramatic increase in reported cases in Italy, which as of March 12, 2020, stand at 15 113.
  3 in total

1.  Covid-19: Italy confirms 11 deaths as cases spread from north.

Authors:  Michael Day
Journal:  BMJ       Date:  2020-02-26

2.  Pandemic potential of a strain of influenza A (H1N1): early findings.

Authors:  Christophe Fraser; Christl A Donnelly; Simon Cauchemez; William P Hanage; Maria D Van Kerkhove; T Déirdre Hollingsworth; Jamie Griffin; Rebecca F Baggaley; Helen E Jenkins; Emily J Lyons; Thibaut Jombart; Wes R Hinsley; Nicholas C Grassly; Francois Balloux; Azra C Ghani; Neil M Ferguson; Andrew Rambaut; Oliver G Pybus; Hugo Lopez-Gatell; Celia M Alpuche-Aranda; Ietza Bojorquez Chapela; Ethel Palacios Zavala; Dulce Ma Espejo Guevara; Francesco Checchi; Erika Garcia; Stephane Hugonnet; Cathy Roth
Journal:  Science       Date:  2009-05-11       Impact factor: 47.728

3.  Estimation of Coronavirus Disease 2019 (COVID-19) Burden and Potential for International Dissemination of Infection From Iran.

Authors:  Ashleigh R Tuite; Isaac I Bogoch; Ryan Sherbo; Alexander Watts; David Fisman; Kamran Khan
Journal:  Ann Intern Med       Date:  2020-03-16       Impact factor: 25.391

  3 in total
  59 in total

1.  Systematic literature search, review and dissemination methodology for the COVID-19 pandemic.

Authors:  Charles Reynard; Daniel Darbyshire; Gabrielle Prager; Anisa Jabeen Nasir Jafar; Mina Naguib; Govind Oliver; Patricia van den Berg; Richard Body; Harriet Ambroziak; Simon Carley
Journal:  BMJ Simul Technol Enhanc Learn       Date:  2021-06-08

2.  The notable global heterogeneity in the distribution of COVID-19 cases and the association with pre-existing parasitic diseases.

Authors:  Taehee Chang; Bong-Kwang Jung; Jong-Yil Chai; Sung-Il Cho
Journal:  PLoS Negl Trop Dis       Date:  2022-10-10

3. 

Authors:  Luca Quartuccio; Francesca Valent; Enrico Pasut; Carlo Tascini; Salvatore De Vita
Journal:  Rev Rhum Ed Fr       Date:  2021-05-14

4.  COMMENTARY ON THE SPECTRUM OF CARDIOPULMONARY PATHOLOGY IN COVID-19.

Authors:  Louis Maximilian Buja; Bihong Zhao; Michelle McDonald; Giulia Ottaviani; Dwayne A Wolf
Journal:  Cardiovasc Pathol       Date:  2021-05-13       Impact factor: 2.185

5.  Reconcile the debate over protective effects of BCG vaccine against COVID-19.

Authors:  Wei Fu; Pei-Chuan Ho; Chia-Lun Liu; Kai-Teh Tzeng; Nawar Nayeem; Jonni S Moore; Li-San Wang; Shin-Yi Chou
Journal:  Sci Rep       Date:  2021-04-16       Impact factor: 4.379

6.  Cucurbit[7]uril as a Broad-Spectrum Antiviral Agent against Diverse RNA Viruses.

Authors:  Jia Quan; Xiangjun Zhang; Yuanfu Ding; Shengke Li; Yang Qiu; Ruibing Wang; Xi Zhou
Journal:  Virol Sin       Date:  2021-05-26       Impact factor: 6.947

7.  Changing trend in the management of head neck cancers during the COVID-19 pandemic.

Authors:  Pradeep Pradhan; C Preetam; Pradipta Kumar Parida; Dillip Kumar Samal
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-13       Impact factor: 3.236

8.  Identification of COVID-19 Spreaders Using Multiplex Networks Approach.

Authors:  Edwin Montes-Orozco; Roman-Anselmo Mora-Gutierrez; Sergio-Gerardo De-Los-Cobos-Silva; Eric-Alfredo Rincon-Garcia; Gilberto-Sinuhe Torres-Cockrell; Jorge Juarez-Gomez; Bibiana Obregon-Quintana; Pedro Lara-Velazquez; Miguel-Angel Gutierrez-Andrade
Journal:  IEEE Access       Date:  2020-07-07       Impact factor: 3.367

9.  Protect Healthcare Workers and Patients from COVID-19: The Experience of Two Tertiary Ophthalmology Care Referral Centers in Italy.

Authors:  Mariacristina Parravano; Enrico Borrelli; Eliana Costanzo; Riccardo Sacconi; Monica Varano; Giuseppe Querques
Journal:  Ophthalmol Ther       Date:  2020-04-24

10.  Forecasting the COVID-19 transmission in Italy based on the minimum spanning tree of dynamic region network.

Authors:  Min Dong; Xuhang Zhang; Kun Yang; Rui Liu; Pei Chen
Journal:  PeerJ       Date:  2021-06-29       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.